Produção Nacional
Revisado por pares
Advanced Drug Delivery Systems Targeting NF-κB in Respiratory Diseases
2021; Future Science Ltd; Volume: 13; Issue: 13 Linguagem: Inglês
10.4155/fmc-2021-0013
ISSN1756-8927
AutoresParteek Prasher, Mousmee Sharma, Dinesh Kumar Chellappan, Gaurav Gupta, Niraj Kumar Jha, Sachin Kumar Singh, Ronan MacLoughlin, Terezinha de Jesus Andreoli Pinto, Raimar Löbenberg, Kamal Dua,
Tópico(s)NF-κB Signaling Pathways
ResumoFuture Medicinal ChemistryVol. 13, No. 13 CommentaryAdvanced drug delivery systems targeting NF-κB in respiratory diseasesParteek Prasher, Mousmee Sharma, Dinesh Kumar Chellappan, Gaurav Gupta, Niraj Kumar Jha, Sachin Kumar Singh, Ronan MacLoughlin, Terezinha J A Pinto, Raimar Löbenberg & Kamal DuaParteek Prasher *Author for correspondence: E-mail Address: parteekchemistry@gmail.comhttps://orcid.org/0000-0002-9412-9424Department of Chemistry, UGC Sponsored Centre for Advanced Studies, Guru Nanak Dev University, Amritsar, 143005, IndiaDepartment of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun, 248007, India, Mousmee Sharma https://orcid.org/0000-0002-7728-5054Department of Chemistry, UGC Sponsored Centre for Advanced Studies, Guru Nanak Dev University, Amritsar, 143005, IndiaDepartment of Chemistry, Uttaranchal University, Arcadia Grant, Dehradun, 248007, India, Dinesh Kumar ChellappanDepartment of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia, Gaurav GuptaSchool of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India, Niraj Kumar JhaDepartment of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida, Uttar Pradesh, 201310, India, Sachin Kumar SinghSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India, Ronan MacLoughlinAerogen, IDA Business Park, Dangan, Galway, H91 HE94, IrelandSchool of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, IrelandSchool of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland, Terezinha J A PintoDepartamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, Butantã, São Paulo, Brazil, Raimar LöbenbergFaculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, T6G 2N8, Canada & Kamal Dua **Author for correspondence: E-mail Address: kamal.dua@uts.edu.auhttps://orcid.org/0000-0002-7507-1159Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, T6G 2N8, CanadaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, 2007, AustraliaPublished Online:5 May 2021https://doi.org/10.4155/fmc-2021-0013AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: drug deliverynanosystemsNF-κBrespiratory diseaseSARSReferences1. Dorrington MG, Fraser IDC. NF-κB signaling in macrophages: dynamics, crosstalk, and signal integration. Front. Immunol. 10, 705 (2019).Crossref, Medline, CAS, Google Scholar2. Schuliga M. NF-kappa B signaling in chronic inflammatory airway disease. Biomolecules 5(3), 1266–1283 (2015).Crossref, Medline, CAS, Google Scholar3. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Dua KWadhwa RPont LGHansbro PMHaghi MWilliams KA (Eds). Academic Press, USA (2020).Google Scholar4. Bioavanta-Bosti (2020). www.novochizol.ch/wp-content/uploads/2020/03/Novochizol_press_release_26.03.2020.pdfGoogle Scholar5. Angelo I, Conte C, Miro A, Quaglia F, Ungaro F. Pulmonary drug delivery: a role of polymeric nanoparticles. Curr. Top. Med. Chem. 15(4), 386–400 (2015).Crossref, Medline, Google Scholar6. Mehta M, Prasher P, Sharma M et al. Advanced drug delivery systems can assist in targeting coronavirus diseases (COVID 19): a hypothesis. Med. Hypotheses 144, 110254 (2020).Crossref, Medline, CAS, Google Scholar7. Panda MK, Panda SK, Singh YD, Jit BP, Behara RK, Dhal NK. Role of nanoparticles and nanomaterials in drug delivery: an overview. In: Advances in Pharmaceutical Biotechnology. Patra JShukla ADas G (Eds). Springer, Singapore (2020).Crossref, Google Scholar8. Park HS, Kim KH, Jang S et al. Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles. Int. J. Nanomedicine 5, 505–515 (2010).Crossref, Medline, CAS, Google Scholar9. Chen B, Chai Q, Xu S et al. Silver nanoparticle-activated COX2/PGE2 axis involves alteration of lung cellular senescence in vitro and in vivo. Ecotoxicol. Environ. Saf. 204, 111070 (2020).Crossref, Medline, CAS, Google Scholar10. Que YM, Fan XQ, Lin XJ et al. Size dependent anti-invasiveness of silver nanoparticles in lung cancer cells. RSC Adv. 9, 21134–21138 (2019).Crossref, CAS, Google Scholar11. He Y, Du Z, Ma S et al. Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenograft tumors in vivo. Int. J. Nanomedicine 11, 1879–1887 (2016).Crossref, Medline, CAS, Google Scholar12. Stepkowski TM, Brzoska K, Kruszewski M. Silver nanoparticle induced changes in the expression of NF-κB related genes are cell type specific and related to the basal activity of NF-κB. Toxicol. In Vitro 28(4), 473–478 (2014).Crossref, Medline, CAS, Google Scholar13. Kimura S, Egashira K, Chen L et al. Nanoparticle-mediated delivery of nuclear factor κB decoy into lungs ameliorates monocrotaline induced pulmonary arterial hypertension. Hypertension 53(5), 877–883 (2009).Crossref, Medline, CAS, Google Scholar14. Lee R, Choi YJ, Jeong MS et al. Hyaluronic acid-decorated glycol chitosan nanoparticles for pH-sensitive controlled release of doxorubicin and celecoxib in non-small cell lung cancer. Bioconjug. Chem. 31(3), 923–932 (2020).Crossref, Medline, CAS, Google Scholar15. DiMatteo M, Reasor MJ. Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol. Appl. Pharmacol. 142(2), 411–421 (1997).Crossref, Medline, CAS, Google Scholar16. Shi S-H, Gao X, Li D et al. A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int. J. Nanomedicine 7, 2601–2611 (2012).Medline, CAS, Google Scholar17. Kawabata Y, Aoki Y, Matsui T et al. Stable dry powder inhaler formulation of tranilast attenuated antigen-evoked airway inflammation in rats. Eur. J. Pharm. Biopharm. 77(1), 178–181 (2011).Crossref, Medline, CAS, Google Scholar18. Li M, Zhang T, Zhu L, Wang R, Jin Y. Liposomal andrographolide dry powder inhalers for treatment of bacterial pneumonia via anti-inflammatory pathway. Int. J. Pharm. 528(1), 163–171 (2017).Crossref, Medline, CAS, Google Scholar19. Mei Q, Deng G, Huang Z et al. Porous COS@SiO2 nanocomposites ameliorate severe acute pancreatitis and associated lung injury by regulating the Nrf2 signaling pathway in mice. Front. Chem. 8, 720 (2020).Crossref, Medline, CAS, Google Scholar20. Yuan R, Xu H, Liu X et al. Zinc-doped copper oxide nanocomposites inhibit the growth of human cancer cells through reactive oxygen species-mediated NFκB activations. ACS Appl. Mater. Interfaces 8(46), 31806–31812 (2016).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByPolysaccharide-Based Nanomedicines Targeting Lung Cancer13 December 2022 | Pharmaceutics, Vol. 14, No. 12Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental modelsEuropean Journal of Pharmacology, Vol. 919 Vol. 13, No. 13 Follow us on social media for the latest updates Metrics Downloaded 65 times History Received 13 January 2021 Accepted 15 April 2021 Published online 5 May 2021 Published in print July 2021 Information© 2021 Newlands PressKeywordsdrug deliverynanosystemsNF-κBrespiratory diseaseSARSFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.No writing assistance was utilized in the production of this manuscript.PDF download
Referência(s)